SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-025415
Filing Date
2020-02-05
Accepted
2020-02-05 16:30:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d884481dsc13ga.htm SC 13G/A 34657
  Complete submission text file 0001193125-20-025415.txt   36467
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filed by) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1227
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Subject) CIK: 0001584137 (see all company filings)

IRS No.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89187 | Film No.: 20579190
SIC: 2834 Pharmaceutical Preparations